Merck is carving out its own place in the evolving HIV treatment space with an FDA approval for its Idvynso, a combination ...

The U.S. Food and Drug Administration has approved Merck's Idvynso (doravirine/islatravir), a new, once-daily, two-drug ...

Activities staff member Robert Hardrick teaches chair tai chi for residents of Broadway House for Continuing Care in New Jersey. (Photo: Courtesy of Broadway House) Nursing home patients with HIV may ...

Tens of thousands of Americans are at risk of losing access to HIV treatment as nearly 20 states tighten eligibility rules for AIDS Drug Assistance Programs, known as ADAPs.

In recent years, the story around HIV has shifted dramatically. What was once viewed as a life sentence is now increasingly seen as a manageable condition. Medication is responsible for much of that ...

Many states are limiting access to HIV medications through ADAP programs as federal funding has remained largely flat despite rising costs. Luis Alvarez/Getty Images Several states are cutting or ...

A Q&A With Shauna Applin, ARNP. AJMC: Despite substantial therapeutic advances since the 1980s, the US is not on pace to achieve the goals of the Ending the HIV Epidemic (EHE) public health initiative ...

Anti-HIV medications suppress the viral load of people living with HIV and provide durable protection against heterosexual transmission a study led by the University of North Carolina at Chapel Hill ...

By Robbie Corey-Boulet and Ngouda Dione DAKAR, April 29 (Reuters) - Fewer patients are visiting some HIV treatment centres in ...